2,7-Dimethyl-5,7-dihydrofuro[3,4-d]pyrimidine
Common Name: |
2,7-Dimethyl-5,7-dihydrofuro[3,4-d]pyrimidine |
IUPAC Name: |
2,7-dimethyl-5,7-dihydrofuro[3,4-d]pyrimidine |
Molecular Formula: |
C10H14O |
SMILES: |
CC1C2=NC(=NC=C2CO1)C |
Inchi: |
1S/C8H10N2O/c1-5-8-7(4-11-5)3-9-6(2)10-8/h3,5H,4H2,1-2H3 |
Inchi Key: |
NFFYLZWKFLCOPG-UHFFFAOYSA-N |
Cas No: |
36267-77-3 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
1 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
2 |
Name |
Value |
Molecular Weight (g/mol) |
150.22 |
Mass (g/mol) |
150.079 |
Molar Refractivity |
46.09 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
0 |
Rings |
2 |
TPSA |
9.23 |
Hetero Atoms |
3 |
Heavy Atoms |
11 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
|
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.60 |
LogP |
1.376 |
iLOGP |
2.54 |
XLOGP3 |
0.84 |
WLOGP |
2.44 |
MLOGP |
2.20 |
ESOL Log S |
-1.30 |
ESOL Solubility (mg/ml) |
7.52 |
ESOL Solubility (mol/l) |
0.05 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-0.62 |
Ali Solubility (mg/ml) |
36.3 |
Ali Solubility (mol/l) |
0.24 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-2.08 |
Silicos-IT Solubility (mg/ml) |
1.24 |
Silicos-IT Solubility (mol/l) |
0.01 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.62 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.666 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.368 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
1 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |